Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives
ChemMedChem · 2026
DOI: 10.1002/cmdc.70493 ↗At a glance
Übersichtsarbeit in ChemMedChem, 2026. Written by Christian S Carnero Canales and 7 co-authors. Institution: BIOMET Laboratorio de Química Bioinorgánica en Medicina, Medioambiente y Tecnología, Facultad de Ciencias de la Universidad Nacional de Ingeniería, L…. Major MEDLINE topics: Leishmaniasis, Malaria, Peptides, Nanoparticles. 256 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Program for Scientific Research and Advanced Studies, Interinstitutional Alliances for Doctoral Programs, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (original language)
Malaria and leishmaniasis continue to impose a substantial health burden, while current therapeutic and diagnostic strategies remain limited by toxicity, prolonged regimens, drug resistance, and restricted field applicability. This review examines recent advances in peptide‐enabled nanoplatforms for both diseases, with emphasis on intracellular targeting, drug delivery, and diagnostic innovation. Antimicrobial peptides, cell‐penetrating peptides, peptoids, mimotopes, and peptide‐functionalized nanocarriers have been explored to improve parasite targeting, intracellular delivery, pharmacokinetics, and antiparasitic efficacy. In parallel, peptide‐ and aptamer‐based nanosensors have expanded the detection of clinically relevant biomarkers, including HRP2, pLDH, GP63, KMP‐11, and kDNA, highlighting their potential for sensitive and modular diagnostics. Despite these advances, translation remains constrained by limited in vivo validation, insufficient pharmacokinetic standardization, incomplete toxicity profiling, poor batch reproducibility, protein corona‐associated variability, and scarce validation under field‐relevant conditions. Peptide‐enabled nanoplatforms are therefore most likely to succeed when aligned with stage‐specific parasite biology, realistic host cell‐targeting requirements, and scalable implementation pathways in endemic settings.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- BIOMET Laboratorio de Química Bioinorgánica en Medicina, Medioambiente y Tecnología, Facultad de Ciencias de la Universidad Nacional de Ingeniería, Lima, Peru.
- School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
- General humanidades, Universidad Continental (UC), Arequipa, Perú.
- School of Pharmacy, Biochemistry and Biotechnology, Universidad Católica Santa María (UCSM), Arequipa, Perú.
ORCID profiles: Christian S Carnero Canales, Ana Clara Lunardi Yagi, Túlio Custódio Reis, Jessica Ingrid Cazorla, Fernando Rogério Pavan
Funding
- National Program for Scientific Research and Advanced Studies
- Interinstitutional Alliances for Doctoral Programs
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Cite
APA
Carnero Canales, C. S., Lunardi Yagi, A. C., Reis, T. C., Cazorla, J. I., Rojas Villar, J., Graminha, M. A., Pastrana Alta, R. Y., & Pavan, F. R. (2026). Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives. ChemMedChem. https://doi.org/10.1002/cmdc.70493
Vancouver
Carnero Canales CS, Lunardi Yagi AC, Reis TC, Cazorla JI, Rojas Villar J, Graminha MA, et al. Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives. ChemMedChem. 2026. doi:10.1002/cmdc.70493
BibTeX
@article{CarneroCanales2026,
author = {Carnero Canales, Christian S and Lunardi Yagi, Ana Clara and Reis, Túlio Custódio and Cazorla, Jessica Ingrid and Rojas Villar, Jade and Graminha, Marcia A and Pastrana Alta, Roxana Yesenia and Pavan, Fernando Rogério},
title = {Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70493}
}
EUVIMED